GRFS Competitors & Alternatives
Compare Grifois, S.A. with similar stocks in the same industry
Pharmaceutical Preparations
GRFS
Main Stock$8.22
Tradestie Score
61
Market Cap
$6.78B
P/E Ratio
13.8
Revenue Growth
0.0%
Analyst Upside
+52.5%
Top Competitors
553 stocks in Pharmaceutical Preparations| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LLY
Eli Lilly & Co.
|
$934.82
|
$739.95B | 40.0 | 57 | Compare |
|
JNJ
Johnson & Johnson
|
$242.77
|
$448.07B | 22.2 | 64 | Compare |
|
ABBV
ABBVIE INC.
|
$208.33
|
$431.71B | 91.8 | 59 | Compare |
|
NVO
Novo-Nordisk A/S
|
$36.80
|
$262.92B | 10.4 | 55 | Compare |
|
AZN
AstraZeneca PLC
|
$202.75
|
$261.56B | 30.1 | 56 | Compare |
|
NVS
Novartis AG
|
$153.82
|
$254.99B | 21.4 | 59 | Compare |
|
ABT
Abbott Laboratories
|
$102.85
|
$232.30B | 27.6 | 59 | Compare |
|
MRK
Merck & Co., Inc.
|
$120.10
|
$225.13B | 16.2 | 62 | Compare |
|
PFE
Pfizer Inc.
|
$28.30
|
$154.70B | 20.6 | 68 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$47.91
|
$121.27B | 20.8 | 64 | Compare |
More GRFS Analysis
Data updated: Apr 02, 2026 | Industry: Pharmaceutical Preparations (SIC 2834)
553 stocks in this industry